… survival in glioma patients (multivariate HR = 1.16, CI = 0.57–2.34). For colorectal cancer, we
found that post-diagnosis tricyclic … Once again, when 3 months post-diagnosis are used to …

… of antidepressants on the overall survival of the studied cohort of lung cancer patients [129]. …
TCAs translated to improved survival in patients with colorectal cancer or glioma showed no …

… Selective serotonin reuptake inhibitors (adjusted OR=1.00, 95% CI=0.94–1.06), tricyclic
antidepressants, serotonin-norepinephrine reuptake inhibitors, and serotonin antagonist and …

… cancers studied were; tricyclic antidepressants and both incidence and survival in a number
of cancer types, particularly glioma; … thesis, investigating NSAID use and colorectal cancer …

… prevention of both colorectal cancer and glioma. The same group of authors in a following
paper [73] assessed the survival of CRC patients who used TCAs post-diagnosis: the authors …

… with shorter survival in patients with gliomas, and patients with gliomas with … antidepressant
use on the risk of glioma [85,86]. Tricyclic antidepressants (TCAs) reduce the risk of glioma …

… patients with either colorectal cancer or glioma, there was no significant mortality reduction
in those who used tricyclic antidepressants (… with increased survival in patients with cancer, …

… , 2 publications included serotonin and norepinephrine reuptake inhibitors (SNRIs), 5
publications included tricyclic antidepressants (TCAs), and 7 publications included other atypical …

… Survival from cancer in young people: An … new cases per year) are the most common
cancers in TYA29. This is in contrast to adults, for whom breast, prostate, lung and bowel cancers …

… patients will be still diagnosed with colon cancer this year [31]. Survival has increased during
the 5 years post-diagnosis in those 150,000 new cases of colon cancer per year in the USA …